Skip to main content

Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Publication ,  Journal Article
Shuster, JJ; Falletta, JM; Pullen, DJ; Crist, WM; Humphrey, GB; Dowell, BL; Wharam, MD; Borowitz, M
Published in: Blood
January 1, 1990

Two hundred fifty-three children with newly diagnosed T-cell acute lymphoblastic leukemia (ALL), who were treated uniformly with modified LSA2L2 therapy, were evaluated using univariate and recursive partition analyses to define clinical or biologic features associated with risk of treatment failure. Overall event-free survival (EFS) at 4 years was 43% (SE = 4%). Factors examined included white blood cell (WBC) level, age, gender, race (black v other), presence of a mediastinal mass, hepatomegaly, splenomegaly, marked lymphadenopathy, hemoglobin level, platelet count, blast cell expression of antigens such as the common acute lymphoblastic leukemia antigen (CALLA, CD10), HLA-DR, and T-cell-associated antigens (CD3, CD4, CD8, CD7, CD5, and THY). Univariate analysis showed that age less than or equal to 5 or less than or equal to 7 years, WBC level less than 10, less than 25, less than 50 or less than 100 x 10(3)/microL, and blast cell expression of CD4, CD8, or CALLA were associated with significantly better EFS, while hepatomegaly and splenomegaly were associated with worse EFS. Recursive partitioning analysis showed that the most important single favorable prognostic factor was a WBC level less than 50 x 10(3)/microL and, for patients with WBC counts below this level, the most important predictor of EFS was blast cell expression of the pan-T antigen defined by the monoclonal antibody (MoAb), L17F12 (CD5). For patients with higher WBC levels, the most important predictor of EFS was blast cell expression of THY antigen. The recursive partitioning analysis defined three groups of patients with widely varied prognoses identified as follows: (1) those with a WBC count less than 50 x 10(3)/microL who lacked massive splenomegaly and had blasts expressing CD5 had the best prognosis (66%, SE = 7%, EFS 4 years, n = 84); (2) those with (b1) WBC counts less than 50 x 10(3)/microL with either massive splenomegaly or who had blasts lacking CD5 expression, or (b2) WBC counts greater than 50 x 10(3)/microL with expression of the THY antigen had an intermediate prognosis (39%, SE = 7% EFS at 4 years, n = 94); (3) those with WBC counts greater than 50 x 10(3)/microL and whose blasts lacked expression of THY antigen had the poorest outcome (EFS = 19% at 4 years, SE = 8%, n = 63). A three-way comparison of EFS according to these groupings showed significant differences among the three patient groups (P less than .001). The recursive partitioning was able to classify 241 (95%) of the patients.(ABSTRACT TRUNCATED AT 400 WORDS)

Duke Scholars

Published In

Blood

ISSN

0006-4971

Publication Date

January 1, 1990

Volume

75

Issue

1

Start / End Page

166 / 173

Location

United States

Related Subject Headings

  • Thy-1 Antigens
  • Statistics as Topic
  • Retrospective Studies
  • Prognosis
  • Multicenter Studies as Topic
  • Leukocyte Count
  • Leukemia-Lymphoma, Adult T-Cell
  • Immunology
  • Humans
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shuster, J. J., Falletta, J. M., Pullen, D. J., Crist, W. M., Humphrey, G. B., Dowell, B. L., … Borowitz, M. (1990). Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood, 75(1), 166–173.
Shuster, J. J., J. M. Falletta, D. J. Pullen, W. M. Crist, G. B. Humphrey, B. L. Dowell, M. D. Wharam, and M. Borowitz. “Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.Blood 75, no. 1 (January 1, 1990): 166–73.
Shuster JJ, Falletta JM, Pullen DJ, Crist WM, Humphrey GB, Dowell BL, et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990 Jan 1;75(1):166–73.
Shuster, J. J., et al. “Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.Blood, vol. 75, no. 1, Jan. 1990, pp. 166–73.
Shuster JJ, Falletta JM, Pullen DJ, Crist WM, Humphrey GB, Dowell BL, Wharam MD, Borowitz M. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990 Jan 1;75(1):166–173.

Published In

Blood

ISSN

0006-4971

Publication Date

January 1, 1990

Volume

75

Issue

1

Start / End Page

166 / 173

Location

United States

Related Subject Headings

  • Thy-1 Antigens
  • Statistics as Topic
  • Retrospective Studies
  • Prognosis
  • Multicenter Studies as Topic
  • Leukocyte Count
  • Leukemia-Lymphoma, Adult T-Cell
  • Immunology
  • Humans
  • Child